Help protect your patients by reducing their risk of CKD progression 1,2 1,2 For adults with T2D, for the primary composite endpoint: Time to first occurrence of 50% sustained eGFR decline, kidney failure (sustained eGFR 100 mg/g and 300 mg/g at baseline)
Preparing injectables outside a USP 797-compliant facility introduces contamination risk patients cannot see, including bacterial, fungal, and particulate contamination that can cause injection-site infections, systemic infections, and in severe cases sepsis
2022;15:1430 Lewis AL, McEntee N, Holland J, Patel A
1,2 At baseline, 95% of patients were treated with an ACE inhibitor or ARB, 16% were on an SGLT-2i, 76% were on a statin, and 50% were on an antiplatelet agent
EAC=external adjudication committee
he sees a plausible future for it in areas like addiction, where the anti-inflammatory effects may matter more than appetite suppression, while stressing it has barely been studied